Literature DB >> 2514950

Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro.

R M Eglen1, R L Whiting.   

Abstract

1. Enprostil is composed, in approximately equal proportions, of 4 allenic isomers which are prostanoids structurally related to prostaglandin E2 (PGE2). The isomers are denoted as RS-86505-007, RS-86812-007 which are in the 'natural' R and S configuration (with respect to PGE2) and RS-86505-008 and RS-86812-008 which are in the 'unnatural' R and S configuration. In the present study we have characterized their activity at prostanoid receptors, in vitro. 2. Enprostil acted as a highly potent (-log EC50 = 8.30 +/- 0.08; mean +/- s.e.mean, n = 6) EP3 receptor agonist in the guinea-pig vas deferens, although no activity was observed at guinea-pig tracheal EP2 receptors at concentrations up to and including 10 microM. Attempts to study the action of enprostil at EP1 receptors were complicated by a general increase in the spontaneous activity of the guinea-pig isolated ileum. This response was stereospecific (i.e. observed, with the 'natural' R and S isomers only) and was not mediated through EP1, FP or TP receptors. 3. Enprostil also exhibited a potent agonist effect at FP and TP receptors in the rat colon and guinea-pig aorta (-log EC50 values = 7.34 +/- 0.11 and 6.54 +/- 0.07, mean +/- s.e. mean, n = 4-8 respectively). No activity at concentrations up to and including 10 microM was observed at DP or IP receptors in the guinea-pig platelet mediating inhibition of ADP-induced aggregation. 4. A similar profile was observed with the 'natural' R and S allenic isomers of enprostil (RS-86505- 007 and RS-86812-007, respectively); RS-86505-007 was between 4 and 10 fold more potent than the racemic enprostil. The 'unnatural' allenic R and S isomers of enprostil were much less potent than enprostil, with the latter being virtually inactive. 5. Enprostil and the 'natural' R and S isomers, therefore, were EP3, FP and TP agonists, being most potent at the EP3 receptor. The preferred configurations for these receptors appears to be the R, and to a lesser extent the S, form of the natural allenic isomer. The effect of enprostil at EP1 receptors was not characterized in view of the presence of excitatory EP3 receptors in the guineapig ileum. These data were in accordance with the pharmacological activity of enprostil, including inhibition of gastric acid secretion (possibly EP3) and diaorrhea (possibly TP).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514950      PMCID: PMC1854831          DOI: 10.1111/j.1476-5381.1989.tb12682.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Prostaglandin-induced neurotransmission failure in the field-stimulated, isolated vas deferens.

Authors:  P Hedqvist; U S Von Euler
Journal:  Neuropharmacology       Date:  1972-03       Impact factor: 5.250

2.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

3.  The zig-zag tracheal strip.

Authors:  J Emmerson; D Mackay
Journal:  J Pharm Pharmacol       Date:  1979-11       Impact factor: 3.765

4.  RS-61756-007: a potent and selective thromboxane receptor (TP) agonist.

Authors:  R M Eglen; R L Whiting
Journal:  J Pharm Pharmacol       Date:  1989-05       Impact factor: 3.765

5.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

6.  The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

7.  Studies on the characterisation of prostanoid receptors: a proposed classification.

Authors:  I Kennedy; R A Coleman; P P Humphrey; G P Levy; P Lumley
Journal:  Prostaglandins       Date:  1982-11

8.  Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume, [H+] and mucus synthesis and secretion in the rat.

Authors:  P Tao; D E Wilson
Journal:  Prostaglandins       Date:  1984-09

9.  Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.

Authors:  S Hamid; B J Whittle
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

10.  Effects of putative thromboxane receptor agonists and antagonists on rat small intestinal ion transport.

Authors:  P L Smith; G P McCafferty; J D Fondacaro; M A Wasserman; E Elton; F M Ryan
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

View more
  7 in total

1.  A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.

Authors:  H Giles; M L Bolofo; S J Lydford; G R Martin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

2.  The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

3.  Prostanoid receptors involved in the relaxation of human bronchial preparations.

Authors:  X Norel; L Walch; C Labat; J P Gascard; E Dulmet; C Brink
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Prostanoid receptors involved in the relaxation of human pulmonary vessels.

Authors:  L Walch; C Labat; J P Gascard; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Ontogenic increase in PGE2 and PGF2 alpha receptor density in brain microvessels of pigs.

Authors:  D Y Li; D R Varma; S Chemtob
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Localisation of prostaglandin F2 alpha and E2 binding sites in the human eye.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

7.  Stretchable chiral pockets for palladium-catalyzed highly chemo- and enantioselective allenylation.

Authors:  Yuchen Zhang; Xue Zhang; Shengming Ma
Journal:  Nat Commun       Date:  2021-04-23       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.